Letter to the Editor: Statins and COVID‐19: Efficacy Still to Be Proven - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Hepatology Année : 2021

Letter to the Editor: Statins and COVID‐19: Efficacy Still to Be Proven

Résumé

We read with interest the article by Bloom et al reporting liver biochemistry–associated trends, etiologies, and outcomes in 60 patients with coronavirus disease 2019 (COVID‐19). The authors reported that 69% of the patients had abnormal liver function tests (LFTs) on admission and 93% during their hospital stay, with an aspartate aminotransferase (AST) predominance. These results are similar to our own experience of 234 patients admitted with COVID‐19 according to World Health Organization (WHO) diagnostic guidelines.

Dates et versions

hal-03367867 , version 1 (06-10-2021)

Identifiants

Citer

Lucy Meunier, Magdalena Meszaros, Georges-Philippe Pageaux. Letter to the Editor: Statins and COVID‐19: Efficacy Still to Be Proven. Hepatology, 2021, 73 (2), pp.875. ⟨10.1002/hep.31511⟩. ⟨hal-03367867⟩
17 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More